Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Parissa Tabrizian"'
Publikováno v:
International Journal of Surgery. 82:61-69
The Milan criteria have been the cornerstone of selection policies for patients with hepatocellular carcinoma (HCC) awaiting liver transplantation (LT) globally for over two decades. Many groups have proposed the transplantation of patients with larg
Autor:
Neil Mehta, Maarouf Hoteit, Renu Dhanasekaran, T. Tara Ghaziani, Matthew L. Holzner, Jennifer Guy, Parissa Tabrizian, Leana Frankul, Wesley Chan, Catherine Frenette, Neehar D. Parikh, Brahma Natarajan, Jennifer L. Dodge, Francis Y. Yao, Austin J. Fobar, Sander Florman
Publikováno v:
Gastroenterology, vol 161, iss 5
Gastroenterology
Gastroenterology
Background & aimsUnited Network of Organ Sharing (UNOS) has adopted uniform criteria for downstaging (UNOS-DS) of hepatocellular carcinoma (HCC) before liver transplantation (LT), but the downstaging success rate and intention-to-treat outcomes acros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c888465fabac1d1fcbcbf83e31be0522
https://escholarship.org/uc/item/8rs693pf
https://escholarship.org/uc/item/8rs693pf
Autor:
Constance M. Mobley, Maarouf Hoteit, Debra L. Sudan, David D. Lee, Thomas M. Fishbein, Carol A. Carney, Michael L. Kueht, Alan W. Hemming, Vatche G. Agopian, Karim J. Halazun, Federico Aucejo, Matthew H. Levine, Johnny C. Hong, Amit D. Tevar, Sander Florman, Joseph DiNorcia, Alan N. Langnas, James F. Markmann, Abbas Rana, Goran B. Klintmalm, Joohyun Kim, Elizabeth C. Verna, Richard Ruiz, C. Burcin Taner, Trevor L. Nydam, Beth Amundsen, Mindie H. Nguyen, Abhinav Humar, Ronald W. Busuttil, Neeta Vachharajani, Daniela Markovic, Parissa Tabrizian, Marc L. Melcher, Srinath Senguttuvan, William C. Chapman, Jennifer Berumen, R. Mark Ghobrial, Brandy Haydel, Michael A. Zimmerman, Christopher M. Jones
Publikováno v:
Annals of Surgery. 271:616-624
OBJECTIVE The aim of the study was to determine the rate, predictors, and impact of complete pathologic response (cPR) to pretransplant locoregional therapy (LRT) in a large, multicenter cohort of hepatocellular carcinoma (HCC) patients undergoing li
Autor:
Quirino Lai, Karim J. Halazun, M.B. Majella Doyle, Federico Aucejo, Jans Mittler, Cristiano Quintini, Francis Y. Yao, Jean C. Emond, Benedikt Schaefer, Jan Lerut, Neil Mehta, Robert S. Brown, Tommy Ivanics, Armin Finkenstedt, Andre Gorgen, Samuele Iesari, Parissa Tabrizian, Maria Hoppe-Lotichius, Benjamin Samstein, Massimo Rossi, Kaveh Hajifathalian, William C. Chapman, Gonzalo Sapisochin, Kazunari Sasaki, Vatche G. Agopian, Gagan Brar, Marc Najjar, Russell Rosenblatt, Gianluca Mennini
Publikováno v:
JAMA Surgery, Vol. 156, no. 6, p. 559-567 (2021)
IMPORTANCE: Accurate preoperative prediction of hepatocellular carcinoma (HCC) recurrence after liver transplant is the mainstay of selection tools used by transplant-governing bodies to discern candidacy for patients with HCC. Although progress has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06a3fcd5ae80306a525ada9b0c92108
https://hdl.handle.net/2078.1/246045
https://hdl.handle.net/2078.1/246045
Autor:
Kristopher P. Croome, Erin H. Baker, David M. Nagorney, Charles A. Rickert, Cristina R. Ferrone, Shoko Kimura, Sander Florman, Marc Najjar, Joohyun Kim, Jennifer Pasko, Alan Hemming, Johnny C. Hong, Jessica Lindemann, Parissa Tabrizian, Erin Maynard, Karim J. Halazun, Ronald W. Busuttil, Jane Cheng, Leigh Anne Dageforde, M.B. Majella Doyle, Lavanya Yohanathan, Rami Srouji, William C. Chapman, Gabriel T. Schnickel, Matthew L. Holzner, David A. Lee, Vatche G. Agopian, William R. Jarnagin, Ju Dong Yang, Neeta Vachharajani, Hiral Amin
Publikováno v:
J Am Coll Surg
Journal of the American College of Surgeons, vol 232, iss 4
Journal of the American College of Surgeons, vol 232, iss 4
BackgroundCombined hepatocellular-cholangiocarcinoma liver tumors (cHCC-CCA) with pathologic differentiation of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma within the same tumor are not traditionally considered for liver t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f8f5b05fec9f208aea07404a571bb2
https://europepmc.org/articles/PMC8450541/
https://europepmc.org/articles/PMC8450541/
Publikováno v:
Surgery. 163:698-702
Resection remains the treatment of choice achieving 5-year survival rates of 22% to 40%. The aim of this analysis was to examine the outcomes of patients with solitary ≤5 cm intrahepatic cholangiocarcinoma.A retrospective chart review was performed
Autor:
Sander Florman, Myron Schwartz, Jean C. Emond, Benjamin Samstein, Fabrizio Michelassi, Ronald W. Busuttil, Parissa Tabrizian, Vatche G. Agopian, Robert S. Brown, Marc Najjar, Karim J. Halazun
Publikováno v:
Annals of surgery. 268(4)
OBJECTIVES European liver transplant (LT) centers have moved away from using the Milan Criteria (MC) for hepatocellular carcinoma (HCC) patient selection, turning to models including tumor biological indices, namely alpha-fetoprotein (AFP). We presen
Autor:
Maria Guido, Sasan Roayaie, Swan N. Thung, Juan Del Rio Martin, Francesco D'Amico, Umberto Cillo, Parissa Tabrizian, Thomas D. Schiano, Myron Schwartz, Alessandro Vitale
Publikováno v:
Liver Transplantation. 15:1278-1287
The up-to-seven (Up-to-7) criteria [with 7 being the sum of the size and number of tumors for any given hepatocellular carcinoma (HCC)] have been recently proposed to identify potential candidates for liver transplantation (LT) among patients exceedi
Autor:
Myron Schwartz, Parissa Tabrizian
Publikováno v:
The Mount Sinai journal of medicine, New York. 79(2)
Hepatocellular carcinoma is the sixth most common cancer worldwide and its incidence is rising in Western countries. Liver resection is the treatment of choice in noncirrhotic patients and in cirrhotic patients with well-preserved liver function. Pos